Figure 3
![Figure 3. Characterization of P2X1 activation at the surface of PMNs. (A-B) Expression of CD11b (A), CD11b, CD18, and CD62L (B) at the surface of human PMNs (the gate of PMNs were based on their size (Side Scatter [SS]) and their granulometry (Forward Scatter [FS]) challenged with 10 μM ATP and 0.5 μM phorbol myristate acetate (PMA) (A) or 10 μM α, β-meATP, and 200 U/ml TNF-α (B), (n = 10, *P < .05).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/124/16/10.1182_blood-2014-04-571679/4/2575f3.jpeg?Expires=1735526892&Signature=Ymr2GBDocZiDJHYtppkcI8y7S6GABod7EPX0VsGGKopFK2pMVDtAh6S-wcWtoJOSnKhAp231Lg661NbxI~IcfewsQUn1JQpk7tMTzkEKaWd6~o02IOQIIZt86bSBWZh7LThLzAGXK~gqwPE5fAV6NxqIs2jANTo~8UKBGgeSeVLEGO6PpCUQp-60jLWTGLQR97CN0-PgdXUsks2QuJDsMcDOeMR8oLpMHrBVEKbD2lT3njuPi~QIzQJ4QRVl4YsqTSmD7r19jb8EVruRH6un1AbL3Qw9DTUR46HcrZUgr2eUZboPZNHEDW~NgyArllU3ydJNa6a9z5pFDaklCRYSIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Characterization of P2X1 activation at the surface of PMNs. (A-B) Expression of CD11b (A), CD11b, CD18, and CD62L (B) at the surface of human PMNs (the gate of PMNs were based on their size (Side Scatter [SS]) and their granulometry (Forward Scatter [FS]) challenged with 10 μM ATP and 0.5 μM phorbol myristate acetate (PMA) (A) or 10 μM α, β-meATP, and 200 U/ml TNF-α (B), (n = 10, *P < .05).
